Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Histone Deacetylase Inhibitors Influence Chemotherapy Transport by Modulating Expression and Trafficking of a Common Polymorphic Variant of the ABCG2 Efflux Transporter

3 Apr 2012

Abstract excerpt

Histone deacetylase inhibitors (HDI) have exhibited some efficacy in clinical trials, but it is clear that their most effective applications have yet to be fully determined. In this study, we show that HDIs influence the expression of a common polymorphic variant of the chemotherapy drug efflux transporter ABCG2, which contributes to normal tissue protection. As one of the most frequent variants in human ABCG2,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Epigenetics and DNA Methylation
Share to Pharmacological Effects and Toxicity Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22472121
DOI: 10.1158/0008-5472.can-11-2008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Histone Deacetylase Inhibitors Influence Chemotherapy Transport by Modulating Expression and Trafficking of a Common Polymorphic Variant of the ABCG2 Efflux TransporterPMID 22472121Read ↗

Structure of the human multidrug transporter ABCG2.Semantic proximity Read ↗

Single-nucleotide polymorphisms in a short basic motif in the ABC transporter ABCG2 disable its trafficking out of endoplasmic reticulum and reduce cell resistance to anticancer drugs.Semantic proximity Read ↗

The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicologySemantic proximity Read ↗

The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitorsSemantic proximity Read ↗

Histone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcriptionSemantic proximity Read ↗

Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics.Semantic proximity Read ↗

ABCG2 Transporter Expression Impacts Group 3 Medulloblastoma Response to ChemotherapySemantic proximity Read ↗

Molecular pharmacology of ABCG2 and its role in chemoresistance.Semantic proximity Read ↗

Targeted CRISPR activation and knockout screenings identify novel drug transportersSemantic proximity Read ↗

Histone deacetylase 2 regulates the doxorubicin (Dox) resistance of hepatocarcinoma cells and transcription of ABCB1Semantic proximity Read ↗

Tumor-acquired somatic mutation affects conformation to abolish ABCG2-mediated drug resistance.Semantic proximity Read ↗

Single nucleotide polymorphisms modify the transporter activity of ABCG2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.